Zinc and copper complexes with azacrown ethers and their comparative stability in vitro and in vivo.
Gleb Yu AleshinBayirta V EgorovaAnna B PriselkovaLyubov S ZamuruevaSofia Yu KhabirovaAnastasia D ZubenkoValentina A KarnoukhovaOlga A FedorovaStepan N KalmykovPublished in: Dalton transactions (Cambridge, England : 2003) (2020)
Copper-based radiopharmaceuticals are of high interest these days owing to the decay properties of copper radioisotopes. In contrast, labeled zinc compounds have been less studied for applications in nuclear medicine. In this study, the stability of labeled zinc and copper complexes with two azacrown ether ligands was investigated and compared. Then, the in vitro and in vivo stability of the studied zinc complexes was demonstrated, with the complexes showing promise for biomedical applications. In contrast, analogous copper complexes quickly dissociated in the presence of serum proteins. Furthermore, a simple method for the production of radiochemically pure 65Zn was proposed, and the opportunity for its use as a surrogate radionuclide for research into potential zinc-containing radiopharmaceuticals was demonstrated.